Skip to content

Robotic and Conventional Hand Therapy After Stroke

Robot-assisted Hand Training (Amadeo) Compared With Conventional Physiotherapy Techniques in Chronic Ischemic Stroke Patients: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03020576
Enrollment
31
Registered
2017-01-13
Start date
2011-04-30
Completion date
2016-03-31
Last updated
2018-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Weakness is a major cause of disability in stroke survivors. Rehabilitation techniques are often not effective in restoring full function of the upper limb. Specifically, many individuals remain with weakness in the hand, preventing its return to full use. Robotic therapies have been developed as exercise tools for stroke survivors. Devices, such as the InMotion2, have been shown to be useful in restoring some motor function in the upper limb. However, most existing devices designed to be used with the upper limb have primarily been developed to treat the shoulder, elbow and wrist. They have not specifically addressed hand function. Tyromotion, Inc. has developed the Amadeo, which is primarily intended to provide rehabilitation for patients with neurological or orthopedic deficits in hand function. Initial clinical testing has demonstrated the practicality of using this device in a population of stroke survivors, although further research is needed to better understand the usefulness of the Amadeo device as compared with conventional rehabilitation methods. The purpose of this study was to compare results of training with the Amadeo device or training with conventional therapies. A total of 28 subjects from two separate sites participated in the study and underwent baseline testing of upper limb motor and sensory performance and function. Subjects were then assigned to one of two treatment groups with a 50:50 chance of being in either group. One group underwent training with the Amadeo device and the other group underwent training with conventional therapy. All training sessions were 60 minutes in duration, three days/week for eight weeks (24 total sessions). Subjects were reassessed on completion of the training program.

Interventions

DEVICEAmadeo Hand Robot Device

This is a robotic device designed to offer rehabilitation to remediate weakness and limitations of range of motion of the hand and fingers.

OTHERConventional Therapy

This arm involves treatment using conventional methods designed to promote range of motion, strength, coordination and function at the level of the shoulder, elbow, wrist and hand.

Sponsors

Medical University Innsbruck
CollaboratorOTHER
New York University
CollaboratorOTHER
Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* history of stroke (\>3 months from time of ictus) * paresis or plegia of the upper extremity.

Exclusion criteria

* severe spasticity (defined on the Ashworth Scale with a score of 4-5) * severe pain despite conventional pain therapy of the paretic upper extremity * swelling, infection, fracture or ulcers of the paretic extremity * arthritis of the hand joints * pregnant * botulinum toxin- therapy to the upper extremity within 3 months prior to study entry * severe contractions

Design outcomes

Primary

MeasureTime frameDescription
Impairment Based Arm Measures - Change in Upper Extremity Portion of the Fugl MeyerThrough study completion, an average of 8 weeks (at baseline and at the 8-week completion point)quantitative performance measure (scale ranging from 0 (minimum) to 66 (maximum) points) of arm and hand impairment. A higher score represents more skilled movements of the arm and hand.

Secondary

MeasureTime frameDescription
Change in Hand and Pinch StrengthThrough study completion, an average of 8 weeksquantitative assessment of hand strength using standard dynamometry measurements in units of kilograms
Change in Motor Activity Log AmountThrough study completion (taken at baseline and at 8-week study completion)quantitative, self report scale measuring the 'Amount' and 'How Well' an individual performs a battery of motor tasks. Maximum score of 150 (raw score) for each 'Amount' and 'How Well' sections. Higher scores reflect better performance.
Change in Mobility and Activities of Daily LivingThrough study completion (taken at baseline and at 8 week study completion)The Barthel Index is a quantitative scale measuring the need for assistance an individual has in performance of tasks of general mobility and activities of daily living. Maximum raw score is 100. Higher values represent better outcomes.
Change in Range of Motion MeasuresThrough study completion, an average of 8 weeksquantitative assessment of the mobility of joints throughout the upper limb using standard goniometric measures. Measured in degrees (0-360 degrees)
Change in Spasticity MeasuresThrough study completion, an average of 8 weeksThe Modified Ashworth Scale is a standardized quantitative assessment of muscle tightness/spasticity during movements of the arm and wrist. It is scored on a scale of 1-5, with higher numbers reflecting a greater severity of spasticity.
Change in Motor Activity Log How WellThrough study completion (taken at baseline and on 8 week study completion)quantitative, self report scale measuring the 'Amount' and 'How Well' an individual performs a battery of motor tasks. Maximum score of 150 (raw score) for each 'Amount' and 'How Well' sections. Higher scores reflect better performance.
Change in Hand DexterityThrough study completion, an average of 8 weeksThe 9 Hole Peg Test was used as a quantitative measure of hand dexterity. The participant is asked to remove the pegs and put them back into the slots in a period of 100 sec. The number of pegs moved is recorded as an overall score.

Countries

Austria, United States

Participant flow

Participants by arm

ArmCount
Conventional Group
The purpose of this group is to provide training that is matched to the robotic group in duration and intensity. Participants randomized to this group receive therapy to the affected/paretic upper limb. This therapy is aimed at improving range of motion, strength and functionality. Similar to the robotic group, treatment sessions occurred three times weekly for eight weeks, and sessions were 60 minutes in duration.
14
Robotic Group
The purpose of this group was to provide robotic based training using the Amadeo Hand Robotic Device (Tyromotion, GmbH, Graz, Austria) as a tool to improve range of motion, strength and functionality of the hand in a population of individuals post stroke. Treatment sessions were conducted three times weekly over eight weeks. Each session was 60 minutes in duration.
14
Total28

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject12

Baseline characteristics

CharacteristicRobotic GroupTotalConventional Group
Age, Continuous54.57 years
STANDARD_DEVIATION 13.8
57.13 years
STANDARD_DEVIATION 15.1
58.14 years
STANDARD_DEVIATION 17.9
Region of Enrollment
Austria
6 Participants16 Participants10 Participants
Region of Enrollment
United States
8 Participants12 Participants4 Participants
Sex: Female, Male
Female
7 Participants10 Participants3 Participants
Sex: Female, Male
Male
7 Participants18 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 140 / 14
serious
Total, serious adverse events
0 / 140 / 14

Outcome results

Primary

Impairment Based Arm Measures - Change in Upper Extremity Portion of the Fugl Meyer

quantitative performance measure (scale ranging from 0 (minimum) to 66 (maximum) points) of arm and hand impairment. A higher score represents more skilled movements of the arm and hand.

Time frame: Through study completion, an average of 8 weeks (at baseline and at the 8-week completion point)

ArmMeasureValue (MEAN)Dispersion
Conventional GroupImpairment Based Arm Measures - Change in Upper Extremity Portion of the Fugl Meyer5.9 change in units on a scaleStandard Deviation 13.7
Robotic GroupImpairment Based Arm Measures - Change in Upper Extremity Portion of the Fugl Meyer2.1 change in units on a scaleStandard Deviation 16.3
Secondary

Change in Hand and Pinch Strength

quantitative assessment of hand strength using standard dynamometry measurements in units of kilograms

Time frame: Through study completion, an average of 8 weeks

ArmMeasureValue (MEAN)Dispersion
Conventional GroupChange in Hand and Pinch Strength1.63 change in kilogramsStandard Deviation 7.8
Robotic GroupChange in Hand and Pinch Strength0.84 change in kilogramsStandard Deviation 5.3
Secondary

Change in Hand Dexterity

The 9 Hole Peg Test was used as a quantitative measure of hand dexterity. The participant is asked to remove the pegs and put them back into the slots in a period of 100 sec. The number of pegs moved is recorded as an overall score.

Time frame: Through study completion, an average of 8 weeks

ArmMeasureValue (MEAN)Dispersion
Conventional GroupChange in Hand Dexterity10.67 units on a scaleStandard Deviation 47.8
Robotic GroupChange in Hand Dexterity-1.12 units on a scaleStandard Deviation 24.3
Secondary

Change in Mobility and Activities of Daily Living

The Barthel Index is a quantitative scale measuring the need for assistance an individual has in performance of tasks of general mobility and activities of daily living. Maximum raw score is 100. Higher values represent better outcomes.

Time frame: Through study completion (taken at baseline and at 8 week study completion)

ArmMeasureValue (MEAN)Dispersion
Conventional GroupChange in Mobility and Activities of Daily Living6.78 units on a scaleStandard Deviation 19.1
Robotic GroupChange in Mobility and Activities of Daily Living-0.36 units on a scaleStandard Deviation 12.3
Secondary

Change in Motor Activity Log Amount

quantitative, self report scale measuring the 'Amount' and 'How Well' an individual performs a battery of motor tasks. Maximum score of 150 (raw score) for each 'Amount' and 'How Well' sections. Higher scores reflect better performance.

Time frame: Through study completion (taken at baseline and at 8-week study completion)

ArmMeasureValue (MEAN)Dispersion
Conventional GroupChange in Motor Activity Log Amount9.35 units on a scaleStandard Deviation 35.1
Robotic GroupChange in Motor Activity Log Amount2.53 units on a scaleStandard Deviation 37.7
Secondary

Change in Motor Activity Log How Well

quantitative, self report scale measuring the 'Amount' and 'How Well' an individual performs a battery of motor tasks. Maximum score of 150 (raw score) for each 'Amount' and 'How Well' sections. Higher scores reflect better performance.

Time frame: Through study completion (taken at baseline and on 8 week study completion)

ArmMeasureValue (MEAN)Dispersion
Conventional GroupChange in Motor Activity Log How Well12.79 units on a scaleStandard Deviation 29.5
Robotic GroupChange in Motor Activity Log How Well2.6 units on a scaleStandard Deviation 35.4
Secondary

Change in Range of Motion Measures

quantitative assessment of the mobility of joints throughout the upper limb using standard goniometric measures. Measured in degrees (0-360 degrees)

Time frame: Through study completion, an average of 8 weeks

ArmMeasureValue (MEAN)Dispersion
Conventional GroupChange in Range of Motion Measures3.53 change in units on a scaleStandard Deviation 0.45
Robotic GroupChange in Range of Motion Measures3.33 change in units on a scaleStandard Deviation 0.8
Secondary

Change in Spasticity Measures

The Modified Ashworth Scale is a standardized quantitative assessment of muscle tightness/spasticity during movements of the arm and wrist. It is scored on a scale of 1-5, with higher numbers reflecting a greater severity of spasticity.

Time frame: Through study completion, an average of 8 weeks

ArmMeasureValue (MEAN)Dispersion
Conventional GroupChange in Spasticity Measures-0.10 change in units on a scaleStandard Deviation 0.3
Robotic GroupChange in Spasticity Measures-0.10 change in units on a scaleStandard Deviation 0.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026